This product is a nitroimidazole derivative that can inhibit the redox reaction of amoeba and break the nitrogen chain of the protozoa. In vitro tests have shown that when the drug concentration is 1~2mg/L, the histolytica amoeba can undergo morphological changes in 6~20 hours and all are killed within 24 hours. When the concentration is 0.2mg/L, the histolytica amoeba can be killed within 72 hours. This product has a strong effect of killing trichomonas, and its mechanism is unknown. Metronidazole has a killing effect on cells and anaerobic microorganisms growing under hypoxic conditions. The metabolites generated when it is reduced in the human body also have anti-anaerobic effects, inhibiting the synthesis of bacterial deoxyribonucleic acid, thereby interfering with the growth and reproduction of bacteria, and ultimately causing bacterial death.

It has antiprotozoan and obligate anaerobic effects. It has inhibitory effects on protozoa such as Trichomonas vaginalis, Entamoeba histolytica and Giardia lamblia. It has antibacterial effects on most anaerobic bacteria such as Bacteroides fragilis, Bacteroides melanin, other Bacteroides, Clostridium, Eubacteria, Fusobacterium, Haemophilus vaginalis, Peptococcus, Peptostreptococcus and Veillonella.

It gradually releases iodine, causing bacterial protein to denature and die. It is effective against bacteria, fungi, and viruses, and has little irritation to tissues.

This product is a broad-spectrum antifungal drug that has antibacterial effects on a variety of fungi, especially Candida albicans. Its mechanism of action is to inhibit the synthesis of fungal cell membranes and affect their metabolic processes.

DMA helicase inhibitor has strong antibacterial effect on Gram-negative bacteria, Gram-positive bacteria and some anaerobic bacteria. There is no cross-resistance between this product and other antibacterial drugs.